News

Podcast: How To Support Advanced Therapies and Breakthrough Medicines in Europe

05 Apr 2017

On the occasion of  the first DIA BioVenture day on 28 March 2017 in Glasgow, Menno Aarnout, Wolfgang Stoiber and EBE’s Barbara Freischem discussed options for solutions to support the development and funding of Advanced Therapies and Breakthrough Medicines in Europe.

Listen to the podcast here

                                                                              
Menno Aarnout                                             Barbara Freischem                              Wolfgang Stoiber
Executive Director                                         Executive Director                               Managing Director
The International Association                     European Biopharmaceutical            JSB Partners
of Mutual Benefit Societies (AIM)               Enterprises (EBE)

Discussions moderated by:

Duane Schulthess
Managing Director
Vital Transformation

See also the EBE Position Paper ‘Europe’s flawed and underfunded biotech ecosystem’

2017-09-06T10:30:06+00:00April 5, 2017|